Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Howard Marks, latest 13F

Ligand Pharmaceuticals

In Howard Marks's portfolio · Oaktree Capital Management

Ticker LGND.CV

Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q4 2020 Reduce 10% 16,797,000 0.3% $15.9M
Q3 2020 Reduce 6% 18,629,000 0.4% $16.9M
Q2 2020 Add 5% 19,826,000 0.4% $17.4M
Q1 2020 Reduce 21% 18,865,000 0.4% $15.6M
Q4 2019 Add 56% 23,903,000 0.2% $20.7M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.